Skip to main content
. 2016 Jun 10;8(6):55. doi: 10.3390/cancers8060055

Figure 4.

Figure 4

The methylation percentage of the individual CpGs in the RASSF1A promoter in thyroid cancer patients, n = 24 (ac) colorectal cancer patients, n = 26; (d) colorectal cancer liver metastasis, n = 5. The individual CpG methylation percentage indicates what percentage of DNA molecules are methylated at this site in the sample.